drugset / Trial / NCT00567164

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

NCT00567164

Phase 3 Completed 1887 enrolled Bayer
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether the study drug is safe and effective.

Timeline

Start
2007-10
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject drospirenone Unknown 3 mg Oral
Subject ethinyl estradiol Small molecule 0.02 mg Oral

Indications